Sigrid S. Skånland

Sigrid S. Skånland, PhD, leads a research group at Oslo University Hospital in Norway, which aims to develop and implement functional precision medicine for patients with B-cell malignancies, in particular chronic lymphocytic leukemia (CLL). By performing functional analyses including ex vivo drug sensitivity screening and single cell signaling analyses, her aim is to identify biomarker signatures that can predict treatment outcomes for the individual patient. In 2020, Skånland was awarded a prestigious European Commission ERA PerMed research grant on tailoring the targeted treatment of chronic lymphocytic leukemia. In 2023, she won the «Researcher of the year» prize at Institute for Cancer Research at Oslo University Hospital.